procarbazine has been researched along with Recrudescence in 157 studies
Procarbazine: An antineoplastic agent used primarily in combination with mechlorethamine, vincristine, and prednisone (the MOPP protocol) in the treatment of Hodgkin's disease.
procarbazine : A benzamide obtained by formal condensation of the carboxy group of 4-[(2-methylhydrazino)methyl]benzoic acid with the amino group of isopropylamine. An antineoplastic chemotherapy drug used for treatment of Hodgkin's lymphoma. Metabolism yields azo-procarbazine and hydrogen peroxide, which results in the breaking of DNA strands.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Temozolomide (TMZ) is an alkylating agent licensed for treatment of high-grade glioma (HGG)." | 9.14 | Temozolomide versus procarbazine, lomustine, and vincristine in recurrent high-grade glioma. ( Beall, S; Brada, M; Collins, VP; Erridge, S; Gabe, R; Gattamaneni, R; Hopkins, K; Lee, SM; Levy, D; Rampling, R; Saran, F; Stenning, S; Thompson, LC, 2010) |
| "To investigate the efficacy of temozolomide (TMZ) in relationship to progression free survival at 6 months (PFS-6), median time to progression (TTP), response rate and toxicity, a phase II study was conducted in patients with recurrent glioblastoma multiforme (GBM) following surgery plus radiotherapy and a first-line regimen based on nitrosourea, procarbazine and vincristine." | 9.10 | Temozolomide in patients with glioblastoma at second relapse after first line nitrosourea-procarbazine failure: a phase II study. ( Amistà, P; Basso, U; Berti, F; Brandes, AA; Ermani, M; Gardiman, M; Iuzzolino, P; Lumachi, F; Monfardini, S; Paris, MK; Turazzi, S, 2002) |
| "A randomized, multicentre, open-label, phase II study compared temozolomide (TMZ), an oral second-generation alkylating agent, and procarbazine (PCB) in 225 patients with glioblastoma multiforme at first relapse." | 9.09 | A phase II study of temozolomide vs. procarbazine in patients with glioblastoma multiforme at first relapse. ( Albright, RE; Brada, M; Bruner, J; Fink, K; Fredericks, R; Friedman, H; Glantz, M; Greenberg, H; Hohl, RJ; Levin, VA; Olson, J; Osoba, D; Phillips, P; Prados, MD; Rampling, R; Selker, RG; Shapiro, W; Spence, A; Vick, NA; Yue, N; Yung, WK; Zaknoen, S, 2000) |
| "The authors investigated objective response rate to high dose methotrexate (HDMTX)-based combination chemotherapy in primary central nervous system lymphoma (PCNSL), and sought to identify factors that influence response to HDMTX-based combination therapy." | 7.77 | Factors influencing the response to high dose methotrexate-based vincristine and procarbazine combination chemotherapy for primary central nervous system lymphoma. ( Kim, YZ; Lee, EH; Sung, KH, 2011) |
| "To evaluate the toxicity and efficacy of a modification of a previously evaluated combination of lomustine, vincristine, procarbazine, and prednisone (LOPP) as a rescue protocol for refractory lymphoma in dogs." | 7.77 | Evaluation of the University of Florida lomustine, vincristine, procarbazine, and prednisone chemotherapy protocol for the treatment of relapsed lymphoma in dogs: 33 cases (2003-2009). ( Barabas, K; Clemente, M; Fahey, CE; Kow, K; Lurie, D; Lyles, S; Milner, RJ; Parfitt, S, 2011) |
| "To the authors' knowledge, there is a scarcity of accurate data regarding the feasibility of standard chemotherapy with procarbazine, lomustine, and vincristine (PCV) in a homogeneous series of patients with primary anaplastic oligodendroglioma (AO) and oligoastrocytoma (AOA) that was recurrent after surgery and standard radiotherapy." | 7.72 | Efficacy and feasibility of standard procarbazine, lomustine, and vincristine chemotherapy in anaplastic oligodendroglioma and oligoastrocytoma recurrent after radiotherapy. A Phase II study. ( Brandes, AA; Coria, B; Danieli, D; Ermani, M; Gardiman, M; Iuzzolino, P; Pasetto, LM; Talacchi, A; Tosoni, A; Vastola, F, 2004) |
| "Temozolomide (TMZ) is an alkylating agent licensed for treatment of high-grade glioma (HGG)." | 5.14 | Temozolomide versus procarbazine, lomustine, and vincristine in recurrent high-grade glioma. ( Beall, S; Brada, M; Collins, VP; Erridge, S; Gabe, R; Gattamaneni, R; Hopkins, K; Lee, SM; Levy, D; Rampling, R; Saran, F; Stenning, S; Thompson, LC, 2010) |
| "The authors administered procarbazine, 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU, lomustine), and vincristine (PCV) to 86 patients with recurrent glioblastoma." | 5.12 | PCV chemotherapy for recurrent glioblastoma. ( Dichgans, J; Dietz, K; Fischer, J; Herrlinger, U; Schmidt, F; Weller, M, 2006) |
| "To investigate the efficacy of temozolomide (TMZ) in relationship to progression free survival at 6 months (PFS-6), median time to progression (TTP), response rate and toxicity, a phase II study was conducted in patients with recurrent glioblastoma multiforme (GBM) following surgery plus radiotherapy and a first-line regimen based on nitrosourea, procarbazine and vincristine." | 5.10 | Temozolomide in patients with glioblastoma at second relapse after first line nitrosourea-procarbazine failure: a phase II study. ( Amistà, P; Basso, U; Berti, F; Brandes, AA; Ermani, M; Gardiman, M; Iuzzolino, P; Lumachi, F; Monfardini, S; Paris, MK; Turazzi, S, 2002) |
| "A randomized, multicentre, open-label, phase II study compared temozolomide (TMZ), an oral second-generation alkylating agent, and procarbazine (PCB) in 225 patients with glioblastoma multiforme at first relapse." | 5.09 | A phase II study of temozolomide vs. procarbazine in patients with glioblastoma multiforme at first relapse. ( Albright, RE; Brada, M; Bruner, J; Fink, K; Fredericks, R; Friedman, H; Glantz, M; Greenberg, H; Hohl, RJ; Levin, VA; Olson, J; Osoba, D; Phillips, P; Prados, MD; Rampling, R; Selker, RG; Shapiro, W; Spence, A; Vick, NA; Yue, N; Yung, WK; Zaknoen, S, 2000) |
| "The effects of various regimens of melphalan combination chemotherapy were evaluated in 508 patients with multiple myeloma." | 5.04 | Remission maintenance therapy for multiple myeloma. ( , 1975) |
| " protocol consisting of: vincristine-prednisone plus surgery and/or radiotherapy as induction treatment, craniocervical radiotherapy and intrathecal methotrexate as CNS preventive treatment and anti-leukemia (6-mercaptopurine, methotrexate and vincristine-prednisone pulses) or anti-lymphoma (COPP) treatment as maintenance, in a randomized trial." | 5.04 | Non-Hodgkin's lymphoma in children: an analysis of 122 cases from Argentina. ( Cebrian-Bonesana, A; Kvicala, R; Lein, JM; Ojeda, FG; Pavlovsky, S; Penchansky, L; Pependieck, C; Roca-Garcia, C; Sackmann-Muriel, S; Schvartzman, E, 1978) |
| "To evaluate the toxicity and efficacy of a modification of a previously evaluated combination of lomustine, vincristine, procarbazine, and prednisone (LOPP) as a rescue protocol for refractory lymphoma in dogs." | 3.77 | Evaluation of the University of Florida lomustine, vincristine, procarbazine, and prednisone chemotherapy protocol for the treatment of relapsed lymphoma in dogs: 33 cases (2003-2009). ( Barabas, K; Clemente, M; Fahey, CE; Kow, K; Lurie, D; Lyles, S; Milner, RJ; Parfitt, S, 2011) |
| "The authors investigated objective response rate to high dose methotrexate (HDMTX)-based combination chemotherapy in primary central nervous system lymphoma (PCNSL), and sought to identify factors that influence response to HDMTX-based combination therapy." | 3.77 | Factors influencing the response to high dose methotrexate-based vincristine and procarbazine combination chemotherapy for primary central nervous system lymphoma. ( Kim, YZ; Lee, EH; Sung, KH, 2011) |
| "To the authors' knowledge, there is a scarcity of accurate data regarding the feasibility of standard chemotherapy with procarbazine, lomustine, and vincristine (PCV) in a homogeneous series of patients with primary anaplastic oligodendroglioma (AO) and oligoastrocytoma (AOA) that was recurrent after surgery and standard radiotherapy." | 3.72 | Efficacy and feasibility of standard procarbazine, lomustine, and vincristine chemotherapy in anaplastic oligodendroglioma and oligoastrocytoma recurrent after radiotherapy. A Phase II study. ( Brandes, AA; Coria, B; Danieli, D; Ermani, M; Gardiman, M; Iuzzolino, P; Pasetto, LM; Talacchi, A; Tosoni, A; Vastola, F, 2004) |
| "One hundred patients with Hodgkin's disease (97 with stage I-II disease at presentation) who relapsed after radiation therapy alone were salvaged with either MOPP or ABVD." | 2.71 | Comparison of MOPP versus ABVD as salvage therapy in patients who relapse after radiation therapy alone for Hodgkin's disease. ( Fisher, DC; Li, S; Mauch, PM; Neuberg, D; Ng, AK; Silver, B; Stevenson, MA, 2004) |
| "Thirty-three evaluable patients with Hodgkin's disease who failed radiotherapy were treated on this phase II study with bleomycin, lomustine, cyclophosphamide, vincristine, procarbazine and prednisone given every 28 days for a minimum of eight courses." | 2.70 | Bleomycin, lomustine, cyclophosphamide, vincristine, procarbazine and prednisone (BLEO-CCVPP) in patients with Hodgkin's disease who relapsed after radiotherapy alone: a long-term follow-up study of the Eastern Cooperative Oncology Group (E3481). ( Bennett, JM; Glick, JH; Habermann, TM; Leong, T; Neiman, RS; Oken, MM; Schuster, S; Wiernik, PH, 2001) |
| "Of our 19 patients with Hodgkin's disease (age range, 6 to 20 years) treated with this regimen, 2 had clinical stage I disease, 10 had stage II, 6 had stage III, and 1 had stage IV." | 2.67 | Vancouver hybrid: preliminary experience in the treatment of Hodgkin's disease in childhood and adolescence. ( Arndt, CA; Chen, MG; Gilchrist, GS; Khan, SP; Matsumoto, JM; O'Fallon, WM; Schomberg, PJ; Smithson, WA, 1994) |
| "Relapses were most frequent in previously involved unirradiated areas." | 2.67 | Management of relapse and survival in advanced stage Hodgkin's disease: the EORTC experience. ( Breed, WP; Burgers, JM; Carde, P; de Pauw, BE; Hagenbeek, A; Henry-Amar, M; Monconduit, M; Somers, R; Tarayre, M; Thomas, J, 1991) |
| "From 1976 to 1981, 335 patients with untreated Hodgkin's disease, clinical stages I, II, and IIIA, have been treated by MOPP (nitrogen mustard, vincristine, procarbazine, prednisone) chemotherapy, three to six cycles according to the prognostic factors, combined with radiotherapy." | 2.66 | Extended versus involved fields irradiation combined with MOPP chemotherapy in early clinical stages of Hodgkin's disease. ( Audebert, A; Bernadou, A; Diebold, J; Eghbali, H; Hoerni, B; Krulik, M; Merle-Béral, H; Parlier, Y; Rojouan, J; Zittoun, R, 1985) |
| "In patients with stage IV Hodgkin's disease mechlorethamine, vincristine, procarbazine, and prednisone (MOPP) was randomly tested against MOPP alternated monthly with doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD)." | 2.66 | Alternating non-cross-resistant combination chemotherapy or MOPP in stage IV Hodgkin's disease. A report of 8-year results. ( Bonadonna, G; Santoro, A; Valagussa, P, 1986) |
| "Relapses have been recorded from three years to twenty years, although few very late forms are registered." | 2.40 | Relapse of Hodgkin's disease after 10 years of complete remission: case report. ( Mwanda, OW; Othieno-Abinya, N, 1998) |
| "In most patients with newly diagnosed Hodgkin's disease, initial therapy is curative." | 2.39 | Hodgkin's disease: management of first relapse. ( Horning, SJ; Yuen, AR, 1996) |
| "Patients with advanced Hodgkin's disease not achieving a complete remission with initial MOPP therapy are significantly less responsive to adriamycin and nitrosourea-containing regimens than patients with relapsing disease following a complete remission with MOPP." | 2.37 | Semantics and the chemotherapy of Hodgkin's disease--resistance is not relapse: alternative chemotherapy lacks effectiveness for disease not totally responsive to initial MOPP treatment. ( Coleman, M; Friedlander, RJ, 1988) |
| "After contemporary treatment of ES-HL, relapse mostly occurred > 12 months after first diagnosis." | 1.62 | Relapse After Early-Stage, Favorable Hodgkin Lymphoma: Disease Characteristics and Outcomes With Conventional or High-Dose Chemotherapy. ( Baues, C; Behringer, K; Borchmann, P; Bröckelmann, PJ; Engert, A; Fuchs, M; Guhl, T; Moccia, AA; Müller, H; Pabst, T; Rank, A; Soekler, M; Vieler, T; von Tresckow, B, 2021) |
| "Neutropenia was documented in 20 dogs (57%): 12 grade I to II, 8 grade III to IV." | 1.48 | Evaluation of a multi-agent chemotherapy protocol combining lomustine, procarbazine and prednisolone (LPP) for the treatment of relapsed canine non-Hodgkin high-grade lymphomas. ( Amores-Fuster, I; Blackwood, L; Finotello, R; Harper, A; Killick, DR; Maddox, TW; Mason, SL; Tanis, JB, 2018) |
| "In Tunisia, the management of Adult Hodgkin's Lymphoma (HL) has been standardized since 1999." | 1.48 | [Tunisian National Protocol for Adult Hodgkin's Lymphoma Treatment: Results of a therapeutic regimen adapted to the 2-cycle CT response, about 444 patients]. ( Ben Lakhal, R; BenAhmed, S; BenOthmen, T; BenSalah, H; BenYoussef, Y; Bouaouina, N; Daoued, J; Elloumi, M; Ezzaier, F; Frikha, H; Frikha, M; Hdiji, S; Khelif, A; Laatiri, MA; Ladeb, S; Maalej, M; Meddeb, B; Messai, T; Mezlini, A; Mokrani, A; Msaddek, F; Tebra, S; Toumi, N; Zriba, S, 2018) |
| "Patients who survive Hodgkin lymphoma (HL) are at increased risk of secondary neoplasms (SNs)." | 1.43 | Secondary Neoplasms in Children with Hodgkin's Lymphoma Receiving C-MOPP and Radiotherapy: Presentation of Four Cases. ( Çavdar, A; Ceyhan, K; Deda, H; Gökçora, İH; Gözdaşoğlu, S; Işıkman, E; Pamir, A; Taçyıldız, N; Uluoğlu, Ö; Ünal, E; Yavuz, G, 2016) |
| "Adaptation of patients with Hodgkin's lymphoma can take place only after successful treatment, the probability of relapse and fear of repeated courses strongly interfere with this process, especially in the first years after its closure." | 1.42 | [Hodgkin's lymphoma and radiotherapy]. ( Datsenko, PV; Panshin, GA, 2015) |
| "Only one case of toxic epidermal necrolysis associated with Hodgkin's disease had previously been reported." | 1.40 | [Stevens-Johnson syndrome and Hodgkin's disease: A fortuitous association or paraneoplastic syndrome?]. ( Barbaud, A; Bursztejn, AC; Cribier, B; Cuny, JF; Levy, E; Schmutz, JL; Schoeffler, A; Weinborn, M, 2014) |
| "The behavior of Hodgkin's lymphoma (HL) is different in developing countries, perhaps due to differences in epidemiology and population access to health care." | 1.35 | Comparison between hybrid MOPPABV and ABVD chemotherapy protocols for Hodgkin's lymphoma in public hospitals of the largest South American city: a retrospective 14-year study. ( Alves, AC; Baiocchi, OC; Oliveira, JS; Souza, EM; Zanichelli, MA, 2009) |
| "Adolescent patients with Hodgkin's lymphoma (HL) are treated either in pediatric, or in adult oncological wards." | 1.35 | [Hodgkin's lymphoma in adolescents: where to treat it--in an adult or pediatric institution?]. ( Csóka, M; Deák, B; Gergely, L; Illés, A; Jakab, Z; Keresztes, K; Kovács, G; Molnár, Z; Müller, J; Rosta, A; Schneider, T; Simon, Z; Várady, E, 2008) |
| "Of 6 patients who developed recurrence, 3 (7." | 1.33 | [Comparison of preliminary results of involved-field with extended field radiotherapy combined with chemotherapy for early stage Hodgkin's disease]. ( Han, JZ; Jin, J; Li, YX; Liu, XF; Liu, YP; Song, YW; Wang, SL; Wang, WH; Yu, ZH; Zhou, LQ, 2006) |
| "Intracraneal manifestations of Hodgkin's Disease (HD) are extremely rare, with an estimated incidence rate of approximately 0." | 1.33 | [Limphomatous meningitis as recurrence site in Hodgkin's disease]. ( Corrado, C; Greco, M; Niccodemi, C; Presas, J; Valsecchi, M; Winkel, M, 2006) |
| "Multivariate analysis retained enlarged spleen, involvement of three or more lymph node areas, and bulky disease as significant risk factors for spleen involvement." | 1.32 | Significance of splenomegaly in childhood Hodgkin disease. ( Arya, LS; Bakhshi, S; Dawar, R; Dinand, V; Singh, R; Thavaraj, V, 2004) |
| "Treatment strategies in Hodgkin's disease have an impact on different risk factors." | 1.32 | Does bulky disease at diagnosis influence outcome in childhood Hodgkin's disease and require higher radiation doses? Results from the German-Austrian Pediatric Multicenter Trial DAL-HD-90. ( Dieckmann, K; Heinzl, H; Hofmann, J; Pötter, R; Schellong, G; Wagner, W, 2003) |
| "We transplanted 42 patients with Hodgkin's disease between 1990-1998." | 1.31 | [High-dose chemotherapy and autologous stem cell transplantation for refractory and relapsing Hodgkin's disease as first-line therapy-- studies at Sheba Medical Center--Tel Hashomer]. ( Avigdor, A; Ben-Bassat, I; Grotto, I; Hardan, I; Raanani, P; Shpilberg, O, 2000) |
| "Patients with Hodgkin's disease whose initial complete remissions (CR) after primary chemotherapy were longer than 1 year are thought to have better prognoses than patients whose initial remissions were shorter than 1 year." | 1.29 | Late relapses in Hodgkin's disease: outcome of patients relapsing more than twelve months after primary chemotherapy. ( Aversa, SM; Bianco, A; Chiarion Sileni, V; Fiorentino, MV; Pappagallo, GL; Salvagno, L; Sorarù, M, 1993) |
| "There was no evidence of recurrence of Hodgkin's lymphoma during any episode of nephrotic syndrome." | 1.29 | The successful treatment of recurrent nephrotic syndrome with the MOPP regimen in a patient with a remote history of Hodgkin's disease. ( Delmez, JA; Kissane, JM; Safdar, SH, 1994) |
| "In 74% of the acute myeloid leukemia patients, the truncated inhibitor was detected." | 1.29 | Urinary excretion of proteolyzed alpha1-antitrypsin: specificity, quantitation, and relation to therapy response in patients with acute myeloid leukemia. ( Busch, R; Dengler, R; Eger, G; Emmerich, B; Münstermann, U; Plewan, A, 1995) |
| "Forty-nine patients with Hodgkin's disease who relapsed after a first complete remission of more than 12 months following primary chemotherapy were treated with salvage therapy regimens." | 1.28 | Salvage chemotherapy in Hodgkin's disease. Results in patients relapsing more than twelve months after first complete remission. ( Bonadonna, G; Bonfante, V; Negretti, E; Santoro, A; Valagussa, P; Viviani, S, 1990) |
| "Patients with Hodgkin's disease who were previously untreated with chemotherapy received the chlorambucil, vinblastine, procarbazine, and prednisone (CHLVPP) regimen plus limited involved-field radiation therapy for treatment of Hodgkin's disease through the Nebraska Lymphoma Study Group." | 1.28 | CHLVPP chemotherapy with involved-field irradiation for Hodgkin's disease: favorable results with acceptable toxicity. ( Anderson, JR; Bierman, PJ; Dowling, MD; Howe, D; Hutchins, M; Moravec, DF; Okerbloom, J; Sorensen, S; Vose, JM; Weisenburger, D, 1991) |
| " There were three fatal toxic events, two due to viral infection and one to a second malignant tumor (NHL)." | 1.28 | Hodgkin's disease in children: treatment with MOPP and low-dose, extended field irradiation without laparotomy. Late results and toxicity. ( Berry, M; Blanchette, V; Chan, H; Doherty, M; Doyle, J; Freedman, M; Greenberg, M; Jenkin, D; Panzarella, T; Saunders, F, 1990) |
| "There was no significant difference in recurrence rates between patients without mediastinal mass and patients with a small mass, and in these patients adjuvant chemotherapy MOPP after radiotherapy showed an evident benefit in reducing the relapse rate." | 1.27 | Prognostic significance of large mediastinal involvement in Hodgkin's disease. ( Baccarani, M; Cantore, M; Dominici, G; Emiliani, E; Faedi, M; Fiacchini, M; Frezza, G; Lauria, F; Mazza, P; Sciascia, R, 1983) |
| "Appropriate management of Hodgkin's disease is based on both the stage of disease and the specific anatomic sites of involvement within each stage." | 1.27 | Diagnosis and management of Hodgkin's disease in the adult. ( Fuller, LM; Hagemeister, FB, 1983) |
| "Of 157 patients with Hodgkin's disease treated between 1970 and 1981 an assessment of the clinical course was possible in 134 cases." | 1.27 | [Recurrence in Hodgkin's disease: incidence, therapy and prognosis. (Experience with 134 patients)]. ( Denz, H; Huber, H; Lechleitner, M; Peer, L; Peschel, C, 1983) |
| "Twenty-seven children with Hodgkin's disease were treated with MVOPP (mustine, Velban [vinblastine], Oncovin [vincristine], procarbazine, prednisone) combination chemotherapy." | 1.27 | Hodgkin's disease in children. A ten-year experience in South Africa. ( Hartley, P; Jacobs, P; Karabus, C; King, HS; Werner, D, 1984) |
| "The rate of recurrence formation was found to be in a significant correlation with general symptoms, age, size of the largest cluster of involved lymph nodes, combination of drugs and type of consolidating therapy." | 1.27 | [Peculiarities of the recurrence of lymphogranulomatosis in children following combined chemotherapy]. ( Kharatishvili, ZV; Kolygin, BA, 1983) |
| "The site of relapse is discussed in detail in the text." | 1.27 | Observations on the treatment of mediastinal masses in Hodgkin's disease emphasizing site of failure. ( Chan, PY; Hintz, BL; Kagan, AR; McMahon, J; Nussbaum, H; Rao, AR; Ryoo, MC; Wollin, M, 1987) |
| "The results of treatment of I-II stage Hodgkin's disease in children aged 2-14 have been studied." | 1.27 | [The role of radiotherapy in the treatment of stage I-II Hodgkin's disease in children]. ( Chikrizov, SI; Kanaev, SV; Kolygin, BA; Malinin, AP, 1986) |
| "Between 1967 and 1977, 48 patients with Hodgkin's disease under 16-years-old were treated with MOPP chemotherapy alone at the Uganda Cancer Institute because radiotherapy facilities are not available." | 1.26 | Childhood Hodgkin's disease in Uganda: a ten year experience. ( Katongole-Mbidde, E; Kiire, C; Lwanga, SK; Magrath, I; Olweny, CL; Ziegler, JL, 1978) |
| "Fifteen patients with stage III and IV diffuse histiocytic lymphoma were treated with combination chemotherapy: cyclophosphamide, vincristine sulfate, prednisone, and procarbazine hydrochloride (COPP)." | 1.26 | Diffuse histiocytic lymphoma. The need for aggressive restaging. ( Babick, T; Levitt, M; Weinerman, BH, 1977) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 57 (36.31) | 18.7374 |
| 1990's | 45 (28.66) | 18.2507 |
| 2000's | 35 (22.29) | 29.6817 |
| 2010's | 18 (11.46) | 24.3611 |
| 2020's | 2 (1.27) | 2.80 |
| Authors | Studies |
|---|---|
| Zawati, I | 1 |
| Adouni, O | 1 |
| Finetti, P | 1 |
| Manai, M | 2 |
| Gamoudi, A | 1 |
| Birnbaum, D | 1 |
| Bertucci, F | 1 |
| Mezlini, A | 2 |
| Bröckelmann, PJ | 1 |
| Müller, H | 1 |
| Guhl, T | 1 |
| Behringer, K | 1 |
| Fuchs, M | 1 |
| Moccia, AA | 1 |
| Rank, A | 1 |
| Soekler, M | 1 |
| Vieler, T | 1 |
| Pabst, T | 1 |
| Baues, C | 2 |
| von Tresckow, B | 1 |
| Borchmann, P | 1 |
| Engert, A | 4 |
| Tanis, JB | 1 |
| Mason, SL | 1 |
| Maddox, TW | 1 |
| Blackwood, L | 1 |
| Killick, DR | 1 |
| Amores-Fuster, I | 1 |
| Harper, A | 1 |
| Finotello, R | 1 |
| Ben Lakhal, R | 1 |
| Hdiji, S | 1 |
| Zriba, S | 1 |
| Mokrani, A | 1 |
| Laatiri, MA | 1 |
| BenYoussef, Y | 1 |
| Ezzaier, F | 1 |
| Toumi, N | 1 |
| Ladeb, S | 1 |
| BenSalah, H | 1 |
| Tebra, S | 1 |
| Frikha, H | 1 |
| Messai, T | 1 |
| Daoued, J | 1 |
| Bouaouina, N | 1 |
| Maalej, M | 1 |
| Frikha, M | 1 |
| BenOthmen, T | 1 |
| BenAhmed, S | 1 |
| Khelif, A | 1 |
| Msaddek, F | 1 |
| Elloumi, M | 1 |
| Meddeb, B | 1 |
| Schoeffler, A | 1 |
| Levy, E | 1 |
| Weinborn, M | 1 |
| Cuny, JF | 1 |
| Schmutz, JL | 1 |
| Barbaud, A | 1 |
| Cribier, B | 1 |
| Bursztejn, AC | 1 |
| Shankar, A | 2 |
| Hayward, J | 1 |
| Kirkwood, A | 1 |
| McCarthy, K | 2 |
| Hewitt, M | 2 |
| Morland, B | 1 |
| Daw, S | 2 |
| Englund, A | 1 |
| Hopstadius, C | 1 |
| Enblad, G | 1 |
| Gustafsson, G | 1 |
| Ljungman, G | 1 |
| Kriz, J | 1 |
| Reinartz, G | 1 |
| Dietlein, M | 1 |
| Kobe, C | 1 |
| Kuhnert, G | 1 |
| Haverkamp, H | 1 |
| Haverkamp, U | 1 |
| Engenhart-Cabillic, R | 1 |
| Herfarth, K | 1 |
| Lukas, P | 1 |
| Schmidberger, H | 1 |
| Staar, S | 1 |
| Hegerfeld, K | 1 |
| Eich, HT | 1 |
| Datsenko, PV | 2 |
| Panshin, GA | 1 |
| Gözdaşoğlu, S | 1 |
| Pamir, A | 1 |
| Ünal, E | 1 |
| Gökçora, İH | 1 |
| Uluoğlu, Ö | 1 |
| Ceyhan, K | 1 |
| Deda, H | 1 |
| Işıkman, E | 1 |
| Yavuz, G | 1 |
| Taçyıldız, N | 1 |
| Çavdar, A | 1 |
| Souza, EM | 1 |
| Baiocchi, OC | 1 |
| Zanichelli, MA | 1 |
| Alves, AC | 1 |
| Oliveira, JS | 1 |
| Müller, J | 1 |
| Molnár, Z | 1 |
| Illés, A | 1 |
| Csóka, M | 1 |
| Jakab, Z | 1 |
| Deák, B | 1 |
| Schneider, T | 1 |
| Várady, E | 1 |
| Rosta, A | 1 |
| Simon, Z | 1 |
| Keresztes, K | 1 |
| Gergely, L | 1 |
| Kovács, G | 1 |
| Eckrich, MJ | 1 |
| Domm, J | 1 |
| Ho, R | 1 |
| Whitlock, JA | 1 |
| Frangoul, H | 1 |
| Cavalieri, E | 1 |
| Matturro, A | 1 |
| Annechini, G | 1 |
| De Angelis, F | 1 |
| Frattarelli, N | 1 |
| Gentilini, F | 1 |
| Grapulin, L | 1 |
| Sacco, M | 1 |
| Torelli, F | 1 |
| Vignetti, M | 1 |
| Mandelli, F | 1 |
| Foà, R | 1 |
| Pulsoni, A | 1 |
| Eichenauer, DA | 1 |
| Ruan, J | 2 |
| Martin, P | 2 |
| Coleman, M | 3 |
| Furman, RR | 1 |
| Cheung, K | 1 |
| Faye, A | 1 |
| Elstrom, R | 2 |
| Lachs, M | 1 |
| Hajjar, KA | 1 |
| Leonard, JP | 1 |
| Brada, M | 2 |
| Stenning, S | 1 |
| Gabe, R | 1 |
| Thompson, LC | 1 |
| Levy, D | 1 |
| Rampling, R | 2 |
| Erridge, S | 1 |
| Saran, F | 1 |
| Gattamaneni, R | 1 |
| Hopkins, K | 1 |
| Beall, S | 1 |
| Collins, VP | 1 |
| Lee, SM | 1 |
| Gómez-Herruz, P | 1 |
| Gil-Fernández, JJ | 1 |
| Guillen, H | 1 |
| Arizcorreta, A | 1 |
| Sung, KH | 1 |
| Lee, EH | 1 |
| Kim, YZ | 1 |
| Miwa, A | 1 |
| Sekiguchi, N | 1 |
| Tanimura, A | 1 |
| Homma, C | 1 |
| Shikai, T | 1 |
| Takezako, Y | 1 |
| Yamagata, N | 1 |
| Takezako, N | 1 |
| Fahey, CE | 1 |
| Milner, RJ | 1 |
| Barabas, K | 1 |
| Lurie, D | 1 |
| Kow, K | 1 |
| Parfitt, S | 1 |
| Lyles, S | 1 |
| Clemente, M | 1 |
| Tarasenkova, AA | 2 |
| Filatova, LV | 2 |
| Gershanovich, ML | 2 |
| Semiglazova, TIu | 1 |
| Sato, K | 1 |
| Uchiyama, M | 1 |
| Semiglazov, TIu | 1 |
| Mian, M | 1 |
| Farsad, M | 1 |
| Pescosta, N | 1 |
| Casini, M | 1 |
| Cavattoni, IM | 1 |
| Deola, S | 1 |
| Cortelazzo, S | 1 |
| Brandes, AA | 2 |
| Ermani, M | 2 |
| Basso, U | 1 |
| Paris, MK | 1 |
| Lumachi, F | 1 |
| Berti, F | 1 |
| Amistà, P | 1 |
| Gardiman, M | 2 |
| Iuzzolino, P | 2 |
| Turazzi, S | 1 |
| Monfardini, S | 1 |
| Osorio, G | 1 |
| Caglevic, C | 1 |
| Dieckmann, K | 1 |
| Pötter, R | 1 |
| Hofmann, J | 1 |
| Heinzl, H | 1 |
| Wagner, W | 1 |
| Schellong, G | 1 |
| Schiller, P | 1 |
| Josting, A | 1 |
| Herrmann, R | 1 |
| Koch, P | 2 |
| Sieber, M | 2 |
| Boissevain, F | 1 |
| De Wit, M | 1 |
| Mezger, J | 1 |
| Duhmke, E | 1 |
| Willich, N | 1 |
| Muller, RP | 1 |
| Schmidt, BF | 1 |
| Renner, H | 1 |
| Muller-Hermelink, HK | 1 |
| Pfistner, B | 1 |
| Wolf, J | 1 |
| Hasenclever, D | 2 |
| Loffler, M | 1 |
| Diehl, V | 2 |
| Hodgson, DC | 1 |
| Tsang, RW | 1 |
| Pintilie, M | 1 |
| Sun, A | 1 |
| Wells, W | 1 |
| Crump, M | 1 |
| Gospodarowicz, MK | 1 |
| Mandigers, CM | 1 |
| Verdonck, LF | 1 |
| Meijerink, JP | 1 |
| Dekker, AW | 2 |
| Schattenberg, AV | 1 |
| Raemaekers, JM | 1 |
| Ng, AK | 1 |
| Li, S | 1 |
| Neuberg, D | 1 |
| Silver, B | 3 |
| Stevenson, MA | 1 |
| Fisher, DC | 1 |
| Mauch, PM | 1 |
| Vassilakopoulos, TP | 1 |
| Angelopoulou, MK | 1 |
| Siakantaris, MP | 1 |
| Kontopidou, FN | 1 |
| Dimopoulou, MN | 1 |
| Kokoris, SI | 1 |
| Kyrtsonis, MC | 1 |
| Tsaftaridis, P | 1 |
| Karkantaris, C | 1 |
| Anargyrou, K | 1 |
| Boutsis, DE | 1 |
| Variamis, E | 1 |
| Michalopoulos, T | 1 |
| Boussiotis, VA | 1 |
| Panayiotidis, P | 1 |
| Papavassiliou, C | 1 |
| Pangalis, GA | 1 |
| Tosoni, A | 1 |
| Vastola, F | 1 |
| Pasetto, LM | 1 |
| Coria, B | 1 |
| Danieli, D | 1 |
| Talacchi, A | 1 |
| Arya, LS | 1 |
| Dinand, V | 1 |
| Bakhshi, S | 1 |
| Thavaraj, V | 1 |
| Singh, R | 1 |
| Dawar, R | 1 |
| Balwierz, W | 2 |
| Moryl-Bujakowska, A | 2 |
| Depowska, T | 2 |
| Klekawka, T | 1 |
| Stanuch, H | 1 |
| Matysiak, M | 2 |
| Sopyło, B | 2 |
| Kołakowska-Mrozowska, B | 2 |
| Krenke, K | 1 |
| Chybicka, A | 1 |
| Raś, M | 1 |
| Sońta-Jakimczyk, D | 2 |
| Moszant, A | 1 |
| Wachowiak, J | 1 |
| Kaczmarek-Kanold, M | 2 |
| Kowalczyk, J | 2 |
| Odój, T | 1 |
| Balcerska, A | 1 |
| Drozyńska, E | 1 |
| Wysocki, M | 1 |
| Kołtan, A | 1 |
| Krawczuk-Rybak, M | 1 |
| Stolarska, M | 1 |
| Wessels, G | 1 |
| Bernard Hesseling, P | 1 |
| Campbell, B | 1 |
| Wirth, A | 1 |
| Milner, A | 1 |
| Di Iulio, J | 1 |
| MacManus, M | 1 |
| Ryan, G | 1 |
| Bartlett, NL | 1 |
| Morbidini-Gaffney, S | 1 |
| Alpert, TE | 1 |
| Hatoum, GF | 1 |
| Sagerman, RH | 1 |
| Di Renzo, N | 1 |
| Brugiatelli, M | 1 |
| Montanini, A | 1 |
| Vigliotti, ML | 1 |
| Cervetti, G | 1 |
| Liberati, AM | 1 |
| Luminari, S | 1 |
| Spedini, P | 1 |
| Giglio, G | 1 |
| Federico, M | 2 |
| Fermé, C | 2 |
| Mounier, N | 1 |
| Casasnovas, O | 1 |
| Brice, P | 2 |
| Divine, M | 1 |
| Sonet, A | 1 |
| Bouafia, F | 1 |
| Bastard-Stamatoullas, A | 1 |
| Bordessoule, D | 1 |
| Voillat, L | 1 |
| Reman, O | 1 |
| Blanc, M | 1 |
| Gisselbrecht, C | 1 |
| Schmidt, F | 1 |
| Fischer, J | 1 |
| Herrlinger, U | 1 |
| Dietz, K | 1 |
| Dichgans, J | 1 |
| Weller, M | 1 |
| Wang, WH | 1 |
| Li, YX | 1 |
| Song, YW | 1 |
| Jin, J | 1 |
| Liu, YP | 1 |
| Wang, SL | 1 |
| Zhou, LQ | 1 |
| Liu, XF | 1 |
| Yu, ZH | 1 |
| Han, JZ | 1 |
| Smith, S | 1 |
| Greco, M | 1 |
| Valsecchi, M | 1 |
| Niccodemi, C | 1 |
| Presas, J | 1 |
| Corrado, C | 1 |
| Winkel, M | 1 |
| Majhail, NS | 1 |
| Weisdorf, DJ | 1 |
| Defor, TE | 1 |
| Miller, JS | 1 |
| McGlave, PB | 1 |
| Slungaard, A | 1 |
| Arora, M | 1 |
| Ramsay, NK | 1 |
| Orchard, PJ | 1 |
| MacMillan, ML | 1 |
| Burns, LJ | 1 |
| Hall, GW | 1 |
| Katzilakis, N | 1 |
| Pinkerton, CR | 1 |
| Nicolin, G | 1 |
| Ashley, S | 1 |
| Wallace, WH | 1 |
| Furman, R | 1 |
| Niesvizky, R | 1 |
| George, P | 1 |
| Leonard, J | 1 |
| Kaufmann, T | 1 |
| Sutcliffe, SB | 2 |
| Economopoulos, T | 1 |
| Wrigley, PF | 3 |
| Stansfeld, AG | 1 |
| Malpas, JS | 2 |
| Anderson, H | 2 |
| Deakin, DP | 1 |
| Wagstaff, J | 2 |
| Jones, JM | 1 |
| Todd, ID | 2 |
| Wilkinson, PM | 1 |
| James, RD | 1 |
| Steward, WP | 1 |
| Blackledge, G | 2 |
| Scarffe, JH | 2 |
| Cooper, MR | 1 |
| Pajak, TF | 1 |
| Gottlieb, AJ | 1 |
| Glicksman, AS | 1 |
| Nissen, N | 1 |
| Richards, F | 1 |
| Bloomfield, C | 1 |
| Holland, JF | 1 |
| Crowther, D | 2 |
| Deakin, D | 1 |
| Todd, I | 1 |
| Wilkinson, P | 1 |
| Jones, M | 1 |
| Jacobs, P | 1 |
| King, HS | 1 |
| Karabus, C | 1 |
| Hartley, P | 1 |
| Werner, D | 1 |
| Kovryzhkina, TA | 1 |
| Bayle-Weisgerber, C | 1 |
| Lemercier, N | 1 |
| Teillet, F | 1 |
| Asselain, B | 1 |
| Gout, M | 1 |
| Schweisguth, O | 1 |
| Tsyplenkov, VG | 1 |
| Sviridova, AV | 1 |
| Armata, J | 2 |
| Borkowski, W | 1 |
| Fuller, LM | 3 |
| Hagemeister, FB | 2 |
| Denz, H | 1 |
| Lechleitner, M | 1 |
| Peschel, C | 1 |
| Peer, L | 1 |
| Huber, H | 1 |
| Kolygin, BA | 3 |
| Kharatishvili, ZV | 1 |
| Wagener, DJ | 1 |
| Burgers, JM | 3 |
| Kazem, I | 1 |
| van Peperzeel, HA | 1 |
| Qasim, MM | 1 |
| Sizoo, W | 1 |
| Somers, R | 2 |
| Kroese, WF | 1 |
| Mazza, P | 1 |
| Lauria, F | 2 |
| Sciascia, R | 2 |
| Emiliani, E | 2 |
| Fiacchini, M | 2 |
| Baccarani, M | 2 |
| Frezza, G | 1 |
| Dominici, G | 1 |
| Cantore, M | 1 |
| Faedi, M | 1 |
| Cadman, E | 1 |
| Bloom, AF | 1 |
| Prosnitz, L | 1 |
| Farber, L | 1 |
| Vera, R | 1 |
| Bertino, J | 1 |
| Fischer, D | 1 |
| Lawrence, R | 1 |
| Brusamolino, E | 1 |
| Orlandi, E | 1 |
| Canevari, A | 1 |
| Morra, E | 1 |
| Castelli, G | 1 |
| Alessandrino, EP | 1 |
| Pagnucco, G | 1 |
| Bernasconi, P | 1 |
| Astori, C | 1 |
| Lazzarino, M | 1 |
| Khan, SP | 1 |
| Gilchrist, GS | 1 |
| Arndt, CA | 1 |
| Smithson, WA | 1 |
| Chen, MG | 1 |
| Schomberg, PJ | 1 |
| Matsumoto, JM | 1 |
| O'Fallon, WM | 1 |
| Mjaaland, I | 1 |
| Ganser, D | 1 |
| Freitag, EM | 1 |
| Bohndorf, W | 1 |
| Canellos, GP | 4 |
| Petroni, GR | 1 |
| Barcos, M | 1 |
| Duggan, DB | 1 |
| Peterson, BA | 1 |
| Uematsu, M | 1 |
| Tarbell, NJ | 2 |
| Coleman, CN | 1 |
| Rosenthal, DS | 2 |
| Shulman, LN | 1 |
| Canellos, G | 1 |
| Weinstein, H | 2 |
| Mauch, P | 2 |
| Bader, SB | 1 |
| Niitsu, N | 1 |
| Hara, A | 1 |
| Umeda, M | 1 |
| Shirai, T | 1 |
| Salvagno, L | 1 |
| Sorarù, M | 1 |
| Aversa, SM | 1 |
| Bianco, A | 1 |
| Chiarion Sileni, V | 1 |
| Pappagallo, GL | 1 |
| Fiorentino, MV | 1 |
| Baxter, JD | 1 |
| DiNubile, MJ | 1 |
| Delmez, JA | 1 |
| Safdar, SH | 1 |
| Kissane, JM | 1 |
| Abdallah, JM | 1 |
| Lombardi, DP | 1 |
| Kirsch, IR | 1 |
| Nishikawa, K | 1 |
| Yuen, AR | 1 |
| Horning, SJ | 1 |
| Raez, LE | 1 |
| Temple, JD | 1 |
| Saldana, M | 1 |
| Redei, I | 1 |
| Mangan, KF | 1 |
| Ming, PL | 1 |
| Mullaney, MT | 1 |
| Rao, PN | 1 |
| Goldberg, SL | 1 |
| Klumpp, TR | 1 |
| Barai, U | 1 |
| Teoh, N | 1 |
| Loeffler, M | 1 |
| Pfreundschuh, M | 1 |
| Rühl, U | 1 |
| Nisters-Backes, H | 1 |
| Tesch, H | 1 |
| Franklin, J | 1 |
| Geilen, W | 1 |
| Bartels, H | 1 |
| Cartoni, C | 2 |
| Dölken, G | 1 |
| Enzian, J | 1 |
| Fuchs, R | 1 |
| Gassmann, W | 1 |
| Gerhartz, H | 1 |
| Hagen-Aukamp, U | 1 |
| Hiller, E | 1 |
| Hinkelbein, H | 1 |
| Hinterberger, W | 1 |
| Kirchner, H | 1 |
| Krüger, B | 1 |
| Schwarze, EW | 1 |
| Viviani, S | 3 |
| Camerini, E | 1 |
| Bonfante, V | 2 |
| Santoro, A | 4 |
| Balzarotti, M | 1 |
| Fornier, M | 1 |
| Devizzi, L | 1 |
| Verderio, P | 1 |
| Valagussa, P | 4 |
| Bonadonna, G | 4 |
| Mwanda, OW | 1 |
| Othieno-Abinya, N | 1 |
| van den Bent, MJ | 1 |
| Kros, JM | 1 |
| Heimans, JJ | 1 |
| Pronk, LC | 1 |
| van Groeningen, CJ | 1 |
| Krouwer, HG | 1 |
| Taphoorn, MJ | 1 |
| Zonnenberg, BA | 1 |
| Tijssen, CC | 1 |
| Twijnstra, A | 1 |
| Punt, CJ | 1 |
| Boogerd, W | 1 |
| Dengler, R | 1 |
| Plewan, A | 1 |
| Münstermann, U | 1 |
| Busch, R | 1 |
| Eger, G | 1 |
| Emmerich, B | 1 |
| Kaplan, SS | 1 |
| Rybka, WB | 1 |
| Blom, J | 1 |
| Shekhter-Levin, S | 1 |
| Kamath, SS | 1 |
| Marcus, RB | 1 |
| Lynch, JW | 1 |
| Mendenhall, NP | 1 |
| Bogusławska-Jaworska, J | 1 |
| Pisarek, J | 1 |
| Janik-Moszant, A | 1 |
| Rokicka-Milewska, R | 1 |
| Kołecki, P | 1 |
| Skomra, S | 1 |
| Newecka-Samól, T | 1 |
| Fouillard, L | 1 |
| Laporte, J | 1 |
| Douay, L | 1 |
| Lesage, S | 1 |
| Najman, A | 1 |
| Gourmelon, P | 1 |
| Gorin, NC | 1 |
| Yung, WK | 1 |
| Albright, RE | 1 |
| Olson, J | 1 |
| Fredericks, R | 1 |
| Fink, K | 1 |
| Prados, MD | 1 |
| Spence, A | 1 |
| Hohl, RJ | 1 |
| Shapiro, W | 1 |
| Glantz, M | 1 |
| Greenberg, H | 1 |
| Selker, RG | 1 |
| Vick, NA | 1 |
| Friedman, H | 1 |
| Phillips, P | 1 |
| Bruner, J | 1 |
| Yue, N | 1 |
| Osoba, D | 1 |
| Zaknoen, S | 1 |
| Levin, VA | 2 |
| Chim, CS | 1 |
| Choy, C | 1 |
| Ooi, CG | 1 |
| Liang, R | 1 |
| Avigdor, A | 1 |
| Hardan, I | 1 |
| Shpilberg, O | 1 |
| Raanani, P | 1 |
| Grotto, I | 1 |
| Ben-Bassat, I | 1 |
| Maslovsky, I | 1 |
| Volchek, L | 1 |
| Blumental, R | 1 |
| Ducach, A | 1 |
| Lugassy, G | 1 |
| Wiernik, PH | 2 |
| Leong, T | 1 |
| Oken, MM | 1 |
| Neiman, RS | 1 |
| Habermann, TM | 1 |
| Bennett, JM | 1 |
| Schuster, S | 1 |
| Glick, JH | 1 |
| Chen, YC | 1 |
| Ho, CL | 1 |
| Kao, WY | 1 |
| Hwang, JM | 1 |
| Sheu, LF | 1 |
| Chao, TY | 1 |
| Porzig, KJ | 1 |
| Portlock, CS | 2 |
| Robertson, A | 1 |
| Rosenberg, SA | 4 |
| Kaplan, HS | 3 |
| Glatstein, EJ | 1 |
| Lange, B | 1 |
| Littman, P | 1 |
| Schnaufer, L | 1 |
| Evans, A | 1 |
| Mintz, U | 1 |
| Miller, JB | 1 |
| Golomb, HM | 1 |
| Kinzie, J | 1 |
| Sweet, DL | 1 |
| Lester, EP | 1 |
| Variakojis, D | 1 |
| Roth, NO | 1 |
| Blough, RR | 1 |
| Ferguson, DJ | 1 |
| Ultmann, JE | 1 |
| Vinokurova, NA | 1 |
| Hoffman, WF | 1 |
| Pischer, TL | 1 |
| Seager, ML | 1 |
| Boldrey, EB | 1 |
| Wilson, CB | 1 |
| Weinerman, BH | 1 |
| Levitt, M | 1 |
| Babick, T | 1 |
| Botnick, LE | 1 |
| Goodman, R | 1 |
| Jaffe, N | 1 |
| Filler, R | 1 |
| Cassady, JR | 1 |
| Levi, JA | 1 |
| Madoc-Jones, H | 1 |
| Gamble, JF | 1 |
| Butler, JJ | 1 |
| Sullivan, MP | 1 |
| Fernandez, CH | 1 |
| Gehan, EA | 1 |
| Smith, PG | 1 |
| Wald, N | 1 |
| Jenkin, D | 2 |
| Freedman, M | 2 |
| McClure, P | 1 |
| Peters, V | 1 |
| Saunders, F | 2 |
| Sonley, M | 1 |
| Timothy, AR | 1 |
| Jones, AE | 1 |
| Stout, R | 1 |
| Cebrian-Bonesana, A | 1 |
| Schvartzman, E | 1 |
| Roca-Garcia, C | 1 |
| Pependieck, C | 1 |
| Sackmann-Muriel, S | 1 |
| Ojeda, FG | 1 |
| Kvicala, R | 1 |
| Pavlovsky, S | 1 |
| Lein, JM | 1 |
| Penchansky, L | 1 |
| Babini, L | 1 |
| Franchini, A | 1 |
| Tura, S | 1 |
| Olweny, CL | 2 |
| Katongole-Mbidde, E | 1 |
| Kiire, C | 1 |
| Lwanga, SK | 1 |
| Magrath, I | 2 |
| Ziegler, JL | 2 |
| Young, RC | 4 |
| Chabner, BA | 2 |
| Hubbard, SM | 2 |
| DeVita, VT | 4 |
| Fedoreev, GA | 1 |
| Oberlin, O | 1 |
| Leverger, G | 1 |
| Pacquement, H | 1 |
| Raquin, MA | 1 |
| Chompret, A | 1 |
| Habrand, JL | 1 |
| Terrier-Lacombe, MJ | 1 |
| Bey, P | 1 |
| Bertrand, Y | 1 |
| Rubie, H | 1 |
| Lepage, E | 1 |
| D'Agay, MF | 1 |
| Castaigne, S | 1 |
| Fermand, JP | 1 |
| Frija, J | 1 |
| Miot, C | 1 |
| Brouet, JC | 1 |
| Marty, M | 1 |
| Hoppe, RT | 2 |
| Comer, M | 1 |
| Harvey, AR | 1 |
| Prosnitz, LR | 1 |
| Roberts, KB | 1 |
| Negretti, E | 2 |
| Zanini, M | 1 |
| Zucali, R | 1 |
| Henry-Amar, M | 2 |
| Tarayre, M | 1 |
| Carde, P | 2 |
| Thomas, J | 2 |
| Hagenbeek, A | 1 |
| Monconduit, M | 1 |
| de Pauw, BE | 1 |
| Breed, WP | 1 |
| Biti, GP | 1 |
| Cimino, G | 1 |
| Magrini, SM | 1 |
| Anselmo, AP | 1 |
| Enrici, RM | 1 |
| Bellesi, GP | 1 |
| Bosi, A | 1 |
| Papa, G | 1 |
| Giannarelli, D | 1 |
| Pan'shin, GA | 1 |
| Sotnikov, VM | 1 |
| Korobov, KV | 1 |
| Novikov, ID | 1 |
| Demina, EA | 1 |
| Kondrat'eva, NF | 1 |
| Pirogova, NA | 1 |
| Atamanov, IuA | 1 |
| Malikov, AA | 1 |
| Golovkina, NM | 1 |
| Romantsova, LA | 1 |
| Silinskaia, NV | 1 |
| Longo, DL | 1 |
| Russo, A | 1 |
| Duffey, PL | 1 |
| Glatstein, E | 1 |
| Hill, JB | 1 |
| Jaffe, ES | 1 |
| Velasquez, WS | 1 |
| McLaughlin, P | 1 |
| Redman, JR | 1 |
| Swan, F | 1 |
| Rodriguez, MA | 1 |
| North, L | 1 |
| Dixon, D | 1 |
| Silvermintz, K | 1 |
| Vose, JM | 1 |
| Bierman, PJ | 1 |
| Anderson, JR | 1 |
| Weisenburger, D | 1 |
| Moravec, DF | 1 |
| Sorensen, S | 1 |
| Hutchins, M | 1 |
| Dowling, MD | 1 |
| Howe, D | 1 |
| Okerbloom, J | 1 |
| Mendeleev, IM | 1 |
| Oleĭnik, VA | 1 |
| Miasnikov, AA | 1 |
| Polezhaev, IuN | 1 |
| Glynne-Jones, R | 1 |
| Whitaker, SJ | 1 |
| Plowman, PN | 1 |
| Roach, M | 1 |
| Brophy, N | 1 |
| Cox, R | 1 |
| Varghese, A | 1 |
| Doyle, J | 1 |
| Berry, M | 1 |
| Blanchette, V | 1 |
| Chan, H | 1 |
| Doherty, M | 1 |
| Greenberg, M | 1 |
| Panzarella, T | 1 |
| Rusthoven, JJ | 1 |
| Tubiana, M | 1 |
| Hayat, M | 1 |
| Van der Schueren, E | 1 |
| Noordijk, EM | 1 |
| Tanguy, A | 1 |
| Meerwaldt, JH | 1 |
| Silingardi, V | 1 |
| Frassoldati, A | 1 |
| Barbieri, F | 1 |
| Palomba, G | 1 |
| Mauri, C | 1 |
| Druker, BJ | 1 |
| Friedlander, RJ | 1 |
| Ryoo, MC | 1 |
| Kagan, AR | 1 |
| Wollin, M | 1 |
| Nussbaum, H | 1 |
| Chan, PY | 1 |
| Hintz, BL | 1 |
| Rao, AR | 1 |
| McMahon, J | 1 |
| Kanaev, SV | 1 |
| Malinin, AP | 1 |
| Chikrizov, SI | 1 |
| Zittoun, R | 1 |
| Audebert, A | 1 |
| Hoerni, B | 1 |
| Bernadou, A | 1 |
| Krulik, M | 1 |
| Rojouan, J | 1 |
| Eghbali, H | 1 |
| Merle-Béral, H | 1 |
| Parlier, Y | 1 |
| Diebold, J | 1 |
| Scherer, E | 1 |
| Müller, RD | 1 |
| Schein, PS | 1 |
| McLaren, JH | 1 |
| Papac, RJ | 1 |
| Amiel, JL | 1 |
| Mathé, G | 1 |
| Mbidde, EK | 1 |
| Nkwocha, J | 1 |
| Vermel', AE | 1 |
| Korman, NP | 1 |
| Magagina, GE | 1 |
| Raevskiĭ, IG | 1 |
| Schmidt, CG | 1 |
| Andersen, E | 1 |
| Christensen, BE | 1 |
| Videbaek, A | 1 |
| Nordentoft, AM | 1 |
| Jensen, KB | 1 |
| McElwain, TJ | 1 |
| Hunter, A | 1 |
| Peckham, MJ | 1 |
| Smithers, DW | 1 |
| Fairley, GH | 1 |
| Johnson, RE | 1 |
| Moore, MR | 1 |
| Bull, JM | 1 |
| Jones, SE | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Phase II Trial of Anti-Angiogenic Therapy With RT-PEPC in Patients With Relapsed Mantle Cell Lymphoma[NCT00151281] | Phase 2 | 25 participants (Actual) | Interventional | 2004-11-30 | Completed | ||
| A Prospective Randomised Trial Comparing Temozolomide With PCV In The Treatment Of Recurrent WHO Astrocytic Tumours Grades III And IV[NCT00052455] | Phase 3 | 500 participants (Anticipated) | Interventional | 2002-10-31 | Completed | ||
| Optimization of the Primary Therapy for Patients With Hodgkin's Lymphoma and Evaluation of the Positron Emission Tomography (PET) as a Diagnostic Tool for Primary Staging and Assessment of the Effects of the Therapy[NCT00188149] | Phase 4 | 300 participants | Interventional | 2000-05-31 | Recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
Stromal angiogenesis was assessed using blood vascular and perivascular markers, including VEGFR-1, VEGFR-2, CD34, and a-SMA, as well as lymphatic vascular markers ofVEGFR-3, podoplanin, and Lyve-1. (NCT00151281)
Timeframe: 38 months
| Intervention | pg/mL (Median) |
|---|---|
| RT-PEPC Drug Therapy | 109.5 |
measured by overall Response Rate (ORR), which includes Complete response and partial response. (NCT00151281)
Timeframe: 38 months
| Intervention | percentage of patients (Number) |
|---|---|
| Study Treatment Arm | 73 |
Toxicities were graded according to the National Cancer Institute Common Terminology Criteria for Adverse Events, version 3.0. (NCT00151281)
Timeframe: 38 months
| Intervention | Participants (Count of Participants) | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Grade 3 or 4 neutropenia | Anemia | Thrombocytopenia | Fatigue | Constipation | Cough | Nausea | Neuropathy | Dyspnea | Rash | |
| RT-PEPC Drug Therapy | 14 | 1 | 4 | 22 | 14 | 14 | 13 | 13 | 11 | 10 |
"QoL assessments were obtained with version 3 of the Functional Assessment of Cancer Therapy-General (FACT-G) instrument. The FACT-G is comprised of four subscales: physical well-being (7-items, score range 0-28), social/family well-being (7-items, score range 0-28), emotional well-being (6-items, score range 0-24), and functional well-being (7-items, score range 0-28). Users of the FACT-G are able to generate an overall score and four subscale scores with ranges and distributions that are sample-specific. All questions in the FACT-G use a 5-point rating scale (0 = Not at all to 4 = Very much) A higher number indicates a better Quality of Life, and has a possible range of 0-108 points.~ANOVA was used to compare the difference in the means of total score among the different time points (baseline, every 2M until 6M, and every 6M until PD). The mean of the total FACT-G scores at baseline and mean of total score at all timepoints (using ANOVA) are reported below." (NCT00151281)
Timeframe: baseline, every 2 months until Month 6, and every 6 months until disease progression
| Intervention | FACT-G score (Mean) | |
|---|---|---|
| Mean FACT-G Score at baseline | Mean Total FACT-G Score between all time points | |
| RT-PEPC Drug Therapy | 83.3 | 89.4 |
8 reviews available for procarbazine and Recrudescence
| Article | Year |
|---|---|
Perspectives of the management of childhood lymphoma: experience at Tygerberg Hospital, Western Cape, South Africa.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Blood Transfusion; Child; Combined | 2005 |
[Chemotherapy of relapsed AML and ALL].
Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Cytarabine; Etoposide; Granulocyte Col | 1996 |
Hodgkin's disease: management of first relapse.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplantation; Combined Mod | 1996 |
Relapse of Hodgkin's disease after 10 years of complete remission: case report.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Disease-Free Survival; | 1998 |
The management of Hodgkin's disease in relapse after primary radiation therapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Hodgkin Disease; Humans; Mechlorethamine; Neoplasm S | 1992 |
Combined chemotherapy and radiotherapy for Hodgkin's disease.
Topics: Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Combined Modality Therapy; | 1992 |
Current approaches to the treatment of advanced-stage Hodgkin's disease.
Topics: Adult; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality The | 1986 |
Semantics and the chemotherapy of Hodgkin's disease--resistance is not relapse: alternative chemotherapy lacks effectiveness for disease not totally responsive to initial MOPP treatment.
Topics: Antineoplastic Combined Chemotherapy Protocols; Drug Administration Schedule; Drug Resistance; Hodgk | 1988 |
41 trials available for procarbazine and Recrudescence
| Article | Year |
|---|---|
Relapse analysis of irradiated patients within the HD15 trial of the German Hodgkin Study Group.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cycloph | 2015 |
Efficacy of the BEACOPP regimen in refractory and relapsed Hodgkin lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Aspergillosis; Bleomycin; Cyclophosphamide; D | 2009 |
Durable responses with the metronomic rituximab and thalidomide plus prednisone, etoposide, procarbazine, and cyclophosphamide regimen in elderly patients with recurrent mantle cell lymphoma.
Topics: Aged; Aged, 80 and over; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplas | 2010 |
Temozolomide versus procarbazine, lomustine, and vincristine in recurrent high-grade glioma.
Topics: Adult; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Chi-Square | 2010 |
Ranimustine, ifosfamide, procarbazine, dexamethasone, and etoposide therapy for central nervous system recurrence of diffuse large B-cell lymphoma in patients with poor performance status: a pilot study.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Central Nervous Syst | 2011 |
Temozolomide in patients with glioblastoma at second relapse after first line nitrosourea-procarbazine failure: a phase II study.
Topics: Adult; Aged; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Daca | 2002 |
Involved-field radiotherapy is equally effective and less toxic compared with extended-field radiotherapy after four cycles of chemotherapy in patients with early-stage unfavorable Hodgkin's lymphoma: results of the HD8 trial of the German Hodgkin's Lymph
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide | 2003 |
Comparison of MOPP versus ABVD as salvage therapy in patients who relapse after radiation therapy alone for Hodgkin's disease.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Disease-Free Survival | 2004 |
Vinorelbine, gemcitabine, procarbazine and prednisone (ViGePP) as salvage therapy in relapsed or refractory aggressive non-Hodgkin's lymphoma (NHL): results of a phase II study conducted by the Gruppo Italiano per lo Studio dei Linfomi.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Th | 2006 |
Long-term results and competing risk analysis of the H89 trial in patients with advanced-stage Hodgkin lymphoma: a study by the Groupe d'Etude des Lymphomes de l'Adulte (GELA).
Topics: Adolescent; Adult; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Com | 2006 |
PCV chemotherapy for recurrent glioblastoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Disease Progression; D | 2006 |
Outcome of children with nodular lymphocyte predominant Hodgkin lymphoma - a Children's Cancer and Leukaemia Group report.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Chlorambucil; C | 2007 |
A randomised study of adjuvant chemotherapy after mantle radiotherapy in supradiaphragmatic Hodgkin's disease PS IA-IIB: a report from the Manchester lymphoma group.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; C | 1984 |
The effects of prior radiation therapy and age on the frequency and duration of complete remission among various four-drug treatments for advanced Hodgkin's disease.
Topics: Adult; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Combin | 1984 |
A randomized study comparing chemotherapy alone with chemotherapy followed by radiotherapy in patients with pathologically staged IIIA Hodgkin's disease.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Combined Modality T | 1984 |
Vancouver hybrid: preliminary experience in the treatment of Hodgkin's disease in childhood and adolescence.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplant | 1994 |
Etoposide, vinblastine, and doxorubicin: an active regimen for the treatment of Hodgkin's disease in relapse following MOPP. Cancer and Leukemia Group B.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Disease-Free Survival; Doxorubici | 1995 |
ABMT recommended for relapsed Hodgkin's disease, but better overall survival not yet proved.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplantation; Combined Mod | 1996 |
Multiple statistics for multiple events, with application to repeated infections in the growth factor studies.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Drug Thera | 1997 |
Dose-response relationship of complementary radiotherapy following four cycles of combination chemotherapy in intermediate-stage Hodgkin's disease.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Ther | 1997 |
Childhood stage IV Hodgkin disease: therapeutic results of the Polish pediatric leukemia/lymphoma study group.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; Comb | 1999 |
A phase II study of temozolomide vs. procarbazine in patients with glioblastoma multiforme at first relapse.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Brain Neoplasms; Dacarbazine; | 2000 |
Bleomycin, lomustine, cyclophosphamide, vincristine, procarbazine and prednisone (BLEO-CCVPP) in patients with Hodgkin's disease who relapsed after radiotherapy alone: a long-term follow-up study of the Eastern Cooperative Oncology Group (E3481).
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cause of Death; | 2001 |
Combined modality therapy of Hodgkin's disease: a report on the Stanford Trials.
Topics: Antineoplastic Agents; Clinical Trials as Topic; Drug Therapy, Combination; Female; Hodgkin Disease; | 1978 |
Pathologic stage I and II Hodgkin's disease, 1968--1975: relapse and results of retreatment.
Topics: Adolescent; Adult; Aged; Clinical Trials as Topic; Cyclophosphamide; Drug Therapy, Combination; Fema | 1979 |
The therapeutic implications of splenic involvement in stage IIIA Hodgkin's disease.
Topics: Abdomen; Adolescent; Adult; Child; Drug Therapy, Combination; Female; Hodgkin Disease; Humans; Lymph | 1977 |
New assessment of the prognostic significance of histopathology in Hodgkin's disease for laparotomy-negative stage I and stage II patients.
Topics: Adolescent; Adult; Clinical Trials as Topic; Drug Therapy, Combination; Female; Hodgkin Disease; Hum | 1977 |
Randomised trial of two-drug and four-drug maintenance chemotherapy in advanced or recurrent Hodgkin's disease. Medical Research Council's working party on lymphomas.
Topics: Adult; Drug Therapy, Combination; Female; Follow-Up Studies; Hodgkin Disease; Humans; Male; Mechlore | 1979 |
Non-Hodgkin's lymphoma in children: an analysis of 122 cases from Argentina.
Topics: Adolescent; Antineoplastic Agents; Child; Child, Preschool; Cyclophosphamide; Drug Therapy, Combinat | 1978 |
Remission maintenance therapy for multiple myeloma.
Topics: Bone Neoplasms; Carmustine; Drug Therapy, Combination; Female; Humans; Male; Melphalan; Middle Aged; | 1975 |
Low-dose radiation therapy and reduced chemotherapy in childhood Hodgkin's disease: the experience of the French Society of Pediatric Oncology.
Topics: Actuarial Analysis; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Ch | 1992 |
Hodgkin's disease, clinical stages I, II A-B and IIIA. Results of brief chemotherapy followed by irradiation.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modalit | 1992 |
Alternating versus hybrid MOPP-ABVD in Hodgkin's disease: the Milan experience.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Dacarba | 1991 |
Management of relapse and survival in advanced stage Hodgkin's disease: the EORTC experience.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cause of Death; | 1991 |
Extended-field radiotherapy is superior to MOPP chemotherapy for the treatment of pathologic stage I-IIA Hodgkin's disease: eight-year update of an Italian prospective randomized study.
Topics: Actuarial Analysis; Antineoplastic Combined Chemotherapy Protocols; Female; Hodgkin Disease; Humans; | 1992 |
Alternating non-cross-resistant combination chemotherapy or MOPP in stage IV Hodgkin's disease. A report of 8-year results.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Dox | 1986 |
Toward comprehensive management tailored to prognostic factors of patients with clinical stages I and II in Hodgkin's disease. The EORTC Lymphoma Group controlled clinical trials: 1964-1987.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials as Topic; Combined | 1989 |
Extended versus involved fields irradiation combined with MOPP chemotherapy in early clinical stages of Hodgkin's disease.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; | 1985 |
Maintenance chemotherapy for advanced Hodgkin's disease in remission.
Topics: Blood Cell Count; Blood Platelets; Hodgkin Disease; Humans; Lymphocytes; Mechlorethamine; Nitrosoure | 1973 |
International Symposium on Hodgkin's Disease. Session 5. Treatment. Current status of clinical trials: Stanford experience, 1962-72.
Topics: Biopsy; Clinical Trials as Topic; Drug Therapy, Combination; Follow-Up Studies; Gold Colloid, Radioa | 1973 |
Sequential radiotherapy and chemotherapy in the treatment of Hodgkin's disease. A progress report.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Benzoates; Child; Drug Combinations; Female; Follow- | 1972 |
108 other studies available for procarbazine and Recrudescence
| Article | Year |
|---|---|
Adolescents and young adults with classical Hodgkin lymphoma in northern Tunisia: insights from an adult single-institutional study.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protoc | 2020 |
Relapse After Early-Stage, Favorable Hodgkin Lymphoma: Disease Characteristics and Outcomes With Conventional or High-Dose Chemotherapy.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophos | 2021 |
Evaluation of a multi-agent chemotherapy protocol combining lomustine, procarbazine and prednisolone (LPP) for the treatment of relapsed canine non-Hodgkin high-grade lymphomas.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Dog Diseases; Dogs; Female; Lomustine; Lymp | 2018 |
[Tunisian National Protocol for Adult Hodgkin's Lymphoma Treatment: Results of a therapeutic regimen adapted to the 2-cycle CT response, about 444 patients].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Protoco | 2018 |
[Stevens-Johnson syndrome and Hodgkin's disease: A fortuitous association or paraneoplastic syndrome?].
Topics: Adrenal Cortex Hormones; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Causality | 2014 |
Treatment outcome in children and adolescents with relapsed Hodgkin lymphoma--results of the UK HD3 relapse treatment strategy.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carmustine; Child; Chlorambuc | 2014 |
Hodgkin lymphoma--a survey of children and adolescents treated in Sweden 1985-2009.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; Daca | 2015 |
[Hodgkin's lymphoma and radiotherapy].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Chemotherapy, A | 2015 |
Secondary Neoplasms in Children with Hodgkin's Lymphoma Receiving C-MOPP and Radiotherapy: Presentation of Four Cases.
Topics: Adenoma; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Du | 2016 |
Comparison between hybrid MOPPABV and ABVD chemotherapy protocols for Hodgkin's lymphoma in public hospitals of the largest South American city: a retrospective 14-year study.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Brazil; Dacarbaz | 2009 |
[Hodgkin's lymphoma in adolescents: where to treat it--in an adult or pediatric institution?].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cancer Care Facilities | 2008 |
Autologous stem cell transplant in a patient with Down syndrome and relapsed Hodgkin lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carmustine; Child; Combined Modality Ther | 2009 |
Is there a role for BEACOPP (bleomycin, etoposide, adriamycin, cyclophosphamide, vincristine, procarbazine, prednisone) in relapsed Hodgkin lymphoma?
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Drug Resis | 2009 |
[Fatal Bacillus cereus sepsis and rhabdomyolysis in a patient with Hodgkin's disease].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bacillus cereus; Bacteremia; Bleomycin; Combin | 2011 |
Factors influencing the response to high dose methotrexate-based vincristine and procarbazine combination chemotherapy for primary central nervous system lymphoma.
Topics: Adult; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neo | 2011 |
Evaluation of the University of Florida lomustine, vincristine, procarbazine, and prednisone chemotherapy protocol for the treatment of relapsed lymphoma in dogs: 33 cases (2003-2009).
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Dog Diseases; Dogs; Drug Resistance, Neopla | 2011 |
[Primary refractory and relapsed Hodgkin lymphoma with unfavorable prognosis].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Daca | 2012 |
Isolated central nervous system relapse in a patient with diffuse large B cell lymphoma.
Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Central Nerv | 2012 |
[Relapse in Hodgkin lymphoma].
Topics: Adult; Aged; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclop | 2012 |
Bendamustine salvage for the treatment of relapsed Hodgkin's lymphoma after allogeneic bone marrow transplantation.
Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents, Alkylating; Antineoplastic Combined C | 2013 |
[Relapse of Hodgkin disease after 17 years of complete remission. A case report].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Doxorubici | 2003 |
Does bulky disease at diagnosis influence outcome in childhood Hodgkin's disease and require higher radiation doses? Results from the German-Austrian Pediatric Multicenter Trial DAL-HD-90.
Topics: Adolescent; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Pres | 2003 |
Impact of chest wall and lung invasion on outcome of stage I-II Hodgkin's lymphoma after combined modality therapy.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modalit | 2003 |
Graft-versus-lymphoma effect of donor lymphocyte infusion in indolent lymphomas relapsed after allogeneic stem cell transplantation.
Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemo | 2003 |
Combination chemotherapy plus low-dose involved-field radiotherapy for early clinical stage Hodgkin's lymphoma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Analysis of Variance; Antineoplastic Combined Chemothera | 2004 |
Efficacy and feasibility of standard procarbazine, lomustine, and vincristine chemotherapy in anaplastic oligodendroglioma and oligoastrocytoma recurrent after radiotherapy. A Phase II study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Combined Modality Therapy; | 2004 |
Significance of splenomegaly in childhood Hodgkin disease.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; Cycl | 2004 |
[Over 30-year experience of Polish Pediatric Leukemia/Lymphoma Study Group for treatment of Hodgkin's disease in children and adolescents: improvement curability and decrease of serious complications].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chemotherapy, Adjuvant; Child | 2004 |
Long-term follow-up of salvage radiotherapy in Hodgkin's lymphoma after chemotherapy failure.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Pr | 2005 |
Therapies for relapsed Hodgkin lymphoma: transplant and non-transplant approaches including immunotherapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cycloph | 2005 |
Benign pleural schwannoma secondary to radiotherapy for Hodgkin disease.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Basal Cell; Combin | 2005 |
[Comparison of preliminary results of involved-field with extended field radiotherapy combined with chemotherapy for early stage Hodgkin's disease].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modalit | 2006 |
Something old, something new....
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Drug Resistance, Neoplasm; Gemc | 2006 |
[Limphomatous meningitis as recurrence site in Hodgkin's disease].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biopsy, Needle; Bleomycin; Cisplatin; Cycloph | 2006 |
Long-term results of autologous stem cell transplantation for primary refractory or relapsed Hodgkin's lymphoma.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplant | 2006 |
Low-dose metronomic, multidrug therapy with the PEP-C oral combination chemotherapy regimen for mantle cell lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Etoposide; Humans; Leukocyte Count | 2008 |
Prognosis of Hodgkin's disease: patients who fail to remit or who relapse after combination chemotherapy.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Bleomycin; Child; Child, Preschool; Drug Therapy, Co | 1980 |
Hodgkin's disease in children. A ten-year experience in South Africa.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Female; Follow- | 1984 |
[Treatment of recurrences of lymphogranulomatosis].
Topics: Antineoplastic Combined Chemotherapy Protocols; Hodgkin Disease; Humans; Mechlorethamine; Prednisone | 1984 |
Hodgkin's disease in children. Results of therapy in a mixed group of 178 clinical and pathologically staged patients over 13 years.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Combined Modali | 1984 |
[Evaluation of the efficacy of radiotherapy in the combined treatment of generalized Hodgkin's disease in children].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Combined Modali | 1984 |
MVPP chemotherapy combined with radiotherapy in the treatment of Hodgkin's disease in children: long-term results.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Combined Modali | 1984 |
Diagnosis and management of Hodgkin's disease in the adult.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Drug Therapy, Combination; Ho | 1983 |
[Recurrence in Hodgkin's disease: incidence, therapy and prognosis. (Experience with 134 patients)].
Topics: Antineoplastic Combined Chemotherapy Protocols; Hodgkin Disease; Humans; Mechlorethamine; Mediastina | 1983 |
[Peculiarities of the recurrence of lymphogranulomatosis in children following combined chemotherapy].
Topics: Age Factors; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Child; Cyclophos | 1983 |
Sequential non-cross-resistant chemotherapy regimens (MOPP and CAVmP) in Hodgkin's disease stage IIIB and IV.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; | 1983 |
Prognostic significance of large mediastinal involvement in Hodgkin's disease.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Female | 1983 |
The effective use of combined modality therapy for the treatment of patients with Hodgkin's disease who relapsed following radiotherapy.
Topics: Drug Therapy, Combination; Hodgkin Disease; Humans; Mechlorethamine; Prednisone; Procarbazine; Recur | 1983 |
Results of CAV regimen (CCNU, melphalan, and VP-16) as third-line salvage therapy for Hodgkin's disease.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Dox | 1994 |
[A retrospective analysis of the treatment results in Hodgkin's disease in a radiotherapy clinic].
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined | 1994 |
Wide-field radiation therapy with or without chemotherapy for patients with Hodgkin disease in relapse after initial combination chemotherapy.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child, Preschool | 1993 |
Pediatric stage IV Hodgkin disease. Long-term survival.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Combined Modality Ther | 1993 |
[Treatment with ACVP-16 for relapsed and refractory non-Hodgkin's lymphoma].
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplat | 1993 |
Late relapses in Hodgkin's disease: outcome of patients relapsing more than twelve months after primary chemotherapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Female; | 1993 |
Relapsing chickenpox in a young man with non-Hodgkin's lymphoma.
Topics: Acyclovir; Adult; Antineoplastic Combined Chemotherapy Protocols; Chickenpox; Cyclophosphamide; Doxo | 1994 |
The successful treatment of recurrent nephrotic syndrome with the MOPP regimen in a patient with a remote history of Hodgkin's disease.
Topics: Antineoplastic Combined Chemotherapy Protocols; Hodgkin Disease; Humans; Male; Mechlorethamine; Midd | 1994 |
Genetic instability in patients with Hodgkin's disease undergoing chemotherapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Dox | 1995 |
Successful treatment of lymphomatoid granulomatosis using cyclosporin-A after failure of intensive chemotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; CD4-Positive T-Lymphocytes; Combined Modality Therap | 1996 |
Detection of a dormant 20q- leukemia clone in bone marrow cultures with hematopoietic growth factors: implications for secondary leukemia post-transplant.
Topics: Acute Disease; Adult; Anemia, Refractory, with Excess of Blasts; Antimetabolites, Antineoplastic; An | 1997 |
Soluble interleukin-2 receptors (sIL-2R) in Hodgkin's disease: outcome and clinical implications.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bleomyci | 1998 |
Response rate and prognostic factors of recurrent oligodendroglioma treated with procarbazine, CCNU, and vincristine chemotherapy. Dutch Neuro-oncology Group.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Co | 1998 |
Urinary excretion of proteolyzed alpha1-antitrypsin: specificity, quantitation, and relation to therapy response in patients with acute myeloid leukemia.
Topics: Adult; Aged; alpha 1-Antitrypsin; Aminoglutethimide; Antineoplastic Combined Chemotherapy Protocols; | 1995 |
Tetraploidy in acute myeloid leukemia secondary to large cell lymphoma.
Topics: Acute Disease; Aged; Antineoplastic Combined Chemotherapy Protocols; Blast Crisis; Chromosome Aberra | 1998 |
The impact of radiotherapy dose and other treatment-related and clinical factors on in-field control in stage I and II non-Hodgkin's lymphoma.
Topics: Actuarial Analysis; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Combine | 1999 |
In vivo expansion of reinfused autologous peripheral blood stem cells after a myeloablative regimen, as an alternative to ex vivo expansion pretransplantation: an intriguing observation in apatient autografted twice.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Busulfan; Cyclophosphamide; Doxoru | 1999 |
Hodgkin's disease with primary manifestation in the liver.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Cyclophosphamide; Diagnosis, Different | 2000 |
[High-dose chemotherapy and autologous stem cell transplantation for refractory and relapsing Hodgkin's disease as first-line therapy-- studies at Sheba Medical Center--Tel Hashomer].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carmustine; Combined Modality Ther | 2000 |
Persistent paraneoplastic neurologic syndrome after successful therapy of Hodgkin's disease.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Ataxia; Bleomycin; Combined Modality Therapy; | 2001 |
Adult lymphoblastic lymphoma in Taiwan: an analysis of treatment results of 26 patients.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow T | 2001 |
Treatment of advanced Hodgkin's disease with B-CAVE following MOPP failure.
Topics: Adolescent; Adult; Bleomycin; Doxorubicin; Drug Resistance; Drug Therapy, Combination; Female; Hodgk | 1978 |
Treatment of advanced Hodgkin's disease in pediatric patients.
Topics: Adolescent; Amenorrhea; Antineoplastic Agents; Bone Marrow; Child; Cyclophosphamide; Female; Hodgkin | 1978 |
[Combined chemotherapy in generalized lymphogranulomatosis].
Topics: Adolescent; Adult; Age Factors; Antineoplastic Agents; Drug Therapy, Combination; Drug-Related Side | 1975 |
BCNU-5-fluorouracil combination therapy for recurrent malignant brain tumors.
Topics: Astrocytoma; Bone Marrow; Brain Neoplasms; Carmustine; Drug Therapy, Combination; Fluorouracil; Glio | 1978 |
Diffuse histiocytic lymphoma. The need for aggressive restaging.
Topics: Adult; Aged; Cyclophosphamide; Drug Therapy, Combination; Female; Humans; Lymphoma, Large B-Cell, Di | 1977 |
Stages I--III Hodgkin's disease in children: results of staging and treatment.
Topics: Adolescent; Child; Child, Preschool; Drug Therapy, Combination; Female; Hodgkin Disease; Humans; Lym | 1977 |
Hodgkin's disease in children: treatment with low dose radiation and MOPP without staging laparotomy: a preliminary report.
Topics: Antineoplastic Agents; Child; Drug Therapy, Combination; Female; Hodgkin Disease; Humans; Male; Mech | 1979 |
Hodgkin's disease: combination chemotherapy for relapse following radical radiotherapy.
Topics: Adolescent; Adult; Antineoplastic Agents; Child; Drug Therapy, Combination; Female; Hodgkin Disease; | 1979 |
The treatment of advanced and recurrent Hodgkin's disease with chlorambucil, vinblastine, procarbazine and prednisone in combination.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Bone Marrow; Child; Chlorambucil; Drug Therapy, Comb | 1979 |
[Relapses in Hodgkin's disease and their radiochemotherapy (author's transl)].
Topics: Adult; Antineoplastic Agents; Drug Therapy, Combination; Female; Hodgkin Disease; Humans; Male; Mech | 1978 |
Childhood Hodgkin's disease in Uganda: a ten year experience.
Topics: Adolescent; Antineoplastic Agents; Child; Child, Preschool; Drug Therapy, Combination; Female; Gynec | 1978 |
Patterns of relapse in advanced Hodgkin's disease treated with combination chemotherapy.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Child; Drug Therapy, Combination; Female; Hodgkin Di | 1978 |
Combination chemotherapy of Hodgkin disease in children.
Topics: Adolescent; Child; Child, Preschool; Drug Therapy, Combination; Female; Hodgkin Disease; Humans; Mal | 1975 |
Remission of scleroderma during chemotherapy for lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Female; Hodgkin Disease; Humans; Mechloretham | 1992 |
Salvage chemotherapy in Hodgkin's disease. Results in patients relapsing more than twelve months after first complete remission.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Et | 1990 |
[Risk factors and survival prognosis in lymphogranulomatosis: a statistical analysis].
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Electro | 1991 |
[The combined therapy of stage-II lymphogranulomatosis: the effect of splenectomy and the time period for achieving full remission on treatment efficacy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Hodgkin Disease; Humans; | 1991 |
[The diagnosis and treatment of lymphogranulomatosis in children].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Child; Child, Preschool; Combine | 1991 |
Treatment of advanced-stage massive mediastinal Hodgkin's disease: the case for combined modality treatment.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Combined Modality Therapy; | 1991 |
Two cycles of MOPP and radiotherapy: effective treatment for stage IIIA and IIIB Hodgkin's disease.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Female; Hodgkin Di | 1991 |
CHLVPP chemotherapy with involved-field irradiation for Hodgkin's disease: favorable results with acceptable toxicity.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Analysis of Variance; Antineoplastic Combined Chemothera | 1991 |
[The efficacy of treatment using expanded programs of megavolt irradiation and polychemotherapy in patients with lymphogranulomatosis in stages I, II and IIIA].
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Evaluat | 1990 |
The 'urn' portal; an alternative to the 'mantle' portal in the chemoradiotherapy management of paediatric Hodgkin's disease.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Chlorambucil; C | 1990 |
Prognostic factors for patients relapsing after radiotherapy for early-stage Hodgkin's disease.
Topics: Adolescent; Adult; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Child; Combine | 1990 |
Hodgkin's disease in children: treatment with MOPP and low-dose, extended field irradiation without laparotomy. Late results and toxicity.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Combined Modali | 1990 |
Free-from-failure survival in Hodgkin's disease. Long-term analysis of 148 cases treated with a MOPP-modified protocol.
Topics: Adolescent; Adult; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Child; Combine | 1989 |
Chlorambucil, vinblastine, procarbazine, and prednisone. An effective but less toxic regimen than MOPP for advanced-stage Hodgkin's disease.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Body Weight; Chlorambucil; Female; Hodg | 1989 |
Observations on the treatment of mediastinal masses in Hodgkin's disease emphasizing site of failure.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Child; C | 1987 |
[The role of radiotherapy in the treatment of stage I-II Hodgkin's disease in children].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Combined Modali | 1986 |
[Treatment possibilities of recurrences of lymphogranulomatosis].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclop | 1985 |
Prognosis and survival with extranodal Hodgkin's disease.
Topics: Adult; Carmustine; Chlorambucil; Cyclophosphamide; Drug Therapy, Combination; Hodgkin Disease; Human | 1974 |
[Chemotherapy of Hodgkin's disease].
Topics: Antineoplastic Agents; Bleomycin; Drug Hypersensitivity; Drug Therapy, Combination; Hodgkin Disease; | 1974 |
Letter: Chemotherapy of Hodgkin's disease.
Topics: Adolescent; Child; Child, Preschool; Drug Therapy, Combination; Female; Follow-Up Studies; Hodgkin D | 1974 |
[N-nitrosomethylurea in the chemotherapy of lymphogranulomatosis].
Topics: Adolescent; Adult; Aged; Drug Therapy, Combination; Evaluation Studies as Topic; Female; Hematopoies | 1974 |
[Chemotherapy of lymphogranulomatosis].
Topics: Adolescent; Age Factors; Antineoplastic Agents; Chlorambucil; Cyclophosphamide; Drug Combinations; D | 1974 |
Treatment of Hodgkin's disease. Results obtained by individualized treatment using radiotherapy and cytostatics.
Topics: Adolescent; Adult; Aged; Child; Cyclophosphamide; Female; Hodgkin Disease; Humans; Male; Mechloretha | 1972 |
Combination chemotherapy in Hodgkin's disease.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Carmustine; Child; Female; Hodgkin Disease; Humans; | 1973 |
Combination chemotherapy in advanced and recurrent Hodgkin's disease.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Child; Child, Preschool; Drug Therapy, Combination; | 1973 |
Hodgkin's disease in childhood.
Topics: Adolescent; Antineoplastic Agents; Child; Female; Hodgkin Disease; Humans; Male; Mechlorethamine; Pr | 1973 |